Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
The selective turnover of endoplasmic reticulum via autophagy (ER-phagy) is a fundamentally important pathway that is activated under different stresses to remove misfolded ER proteins or excess ER to ensure overall ER and cellular fitness. Dysregulation of many ER-phagy receptors has been implicated in neurodevelopmental defects, tissue inflammation, and cancer progression. However, additional ER-phagy regulators beyond these ER surface receptors remained under- explored. Using a CRISPR-activation approach, we performed a genome-wide gain-of-function screen, which led to the unexpected discovery of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET)-associated transcription factors as opposing regulators of ER-phagy. We further demonstrated that TGFβ, a physiological EMT activator, also induces ER-phagy. Using proteomics, we found that EMT-induced ER-phagy is required to regulate procollagen degradation. Among FAM134 paralogues which are known ER-phagy receptors, only FAM134A is able to mediate procollagen degradation via a non-canonical, LC3-interacting motif (LIR)-independent manner during EMT. Knockdown of FAM134A reroutes procollagen from ER-phagy to secretion. We further showed that this increase in secretion during EMT promotes matrix invasion. Our findings highlight ER-phagy as an adaptive mechanism during cell state transitions and uncover a context-specific role for FAM134A in modulating the secretory proteome.